All news is rigorously fact-checked and reviewed by leading blockchain experts and seasoned industry insiders.
- Messari reports Injective reaching $6B in RWA perpetual volume, signaling sharp on-chain growth across multiple real-world markets.
- iAssets and on-chain CLOB enable efficient synthetic RWA exposure, accelerating adoption in equities, forex, and commodities.
A recent report from Messari positions Injective (INJ) as an emerging force in the on-chain RWA sector, recording perpetual trading volumes exceeding billions of dollars. The data shows the continued growth of activity on the network, particularly as Injective’s dApps now provide direct access to stocks, forex, commodities, and pre-IPO markets without the need for traditional channels.
Messari’s findings also indicate that the blockchain is moving from a peripheral position to a more central role in facilitating blockchain-based real-world asset trading.
ICYMI: Messari has published a comprehensive report highlighting Injective's growing dominance across RWAs.
Today, dApps on Injective bring unmatched access to fully onchain perpetuals that span equities, forex, commodities, and even pre-IPO markets.
Much more incoming. pic.twitter.com/EWIjIITzMn
— Injective 🥷 (@injective) December 1, 2025
Injective Expands Its Role in the Growing On-Chain RWA Market
Messari noted that RWA perpetual trading volume on the blockchain has reached around $6 billion since early November. This figure indicates growing interest in the network’s on-chain RWA products. Injective’s dApps now provide direct access to a variety of instruments previously only accessible through traditional brokers.
Furthermore, the “Magnificent 7” stock accounted for over 42% of volume, confirming that many traders are using Injective as an alternative route to gain exposure to large-cap assets.
Furthermore, Injective’s iAssets model makes synthetic asset issuance more efficient without the need for excessive collateral. The system relies on oracle data, so prices closely track real-world assets. All trading is now handled by on-chain CLOBs.
A few days earlier, we also reported that Injective had integrated Chainlink Data Streams. This move gives developers access to fast data, helping them accelerate product launch times. However, the core benefit isn’t just speed, but also increased reliability for institutions that demand price stability and a robust oracle architecture.
Meanwhile, in early October, we highlighted that the blockchain had expanded its horizons by introducing an on-chain pre-IPO market, giving traders exposure to the valuations of major companies like OpenAI with up to five times leverage. The contract relies on data from Seda Protocol and Caplight, allowing users to monitor valuation movements without needing to physically own shares.
As of press time, INJ is trading at about $5.28, up 1.71% over the last 4 hours, with $10.84 million in daily spot trading volume.
